Press Releases
List of Services
-
CAVA Robotics International Opens European Office in Berlin
For Immediate Release
Contact: Jason Tuzinkewich
Telephone: 920 / 391-8255
Email: media@cava-robotics.com
Website: cava-robotics.com
September 8, 2021
CAVA Robotics International Opens European Office in Berlin
Reported in PRNewswire
AMHERST, Mass., Sept. 8, 2021 /PRNewswire/ -- CAVA Robotics International announced the opening of its new European headquarters in Berlin, Germany. "CAVA's new Berlin office will help advance our firm's position as the leader in robotic surgery program optimization for hospitals in the US and now Europe," said CAVA president and CEO Josh Feldstein.
The move is part of CAVA's strategy to introduce robotic program improvement in quality, efficiency, profitability, and patient satisfaction to facilities in Germany and throughout Europe. "There is high need for robotic program support – governance, instrument reduction, efficiency, data management, surgeon and crew best practice training, and more – at a highly professional level of support and attention that many European institutions require," said Rainer Kimmig, MD, CAVA's Medical Director in Germany as well as professor and Department Head of Gynecology and Obstetrics at the University of Duisburg-Essen. "Now, by bringing CAVA's peer-reviewed data and validated best practices to Europe, we believe there will be considerable opportunity for robotic surgeons and leading hospital administrators to learn from more than a decade of CAVA's deep US robotic program experience" said Dr. Kimmig. "Our goal is to raise the bar of robotic surgical services and patient healthcare."
Berlin is also an "ideal home for CAVA's European headquarters," said Feldstein. "It boasts strong healthcare quality and innovation as well as an infrastructure of top-tier technical and clinical talent."
"CAVA has an excellent opportunity to impact the global robotic surgery landscape," said York Zoellner, PhD, CAVA's European market advisor who also serves as full professor in Health Economics at Hamburg University of Applied Sciences and holds an affiliation at Charité–University Medicine in Berlin. "Many hospital administrators and surgeons have expressed excitement that CAVA is coming to Germany and Europe generally."
CAVA's team includes European and U.S. surgeons, surgical technicians, health economists, and data scientists who together help to advance the efficiency, profitability, quality, and growth of robotic surgical programs.
"CAVA also works closely with hospitals seeking to launch new robotic programs," said Feldstein. "As the role of robotic technology continues to grow, there is substantial opportunity for surgeons and hospitals with robotic programs to achieve best practice status," Feldstein said.
-
Superior Robotic Surgery Profitability vs. Laparoscopy Reported in New CAVA Robotics’ Journal PublicationList Item 1
For Immediate Release
Contact: Jason Tuzinkewich
Telephone: cell
Email: media@cava-robotics.com
Website: cava-robotics.com
August 2, 2021
Superior Robotic Surgery Profitability vs. Laparoscopy
Reported in New CAVA Robotics’ Journal Publication
AMHERST, MA. Robotic surgery can be more profitable than laparoscopy, according to a new peer review journal study co-authored by CAVA Robotics CEO Josh Feldstein and Dr. Ali Ghomi, Chairman, Department of Obstetrics and Gynecology, Sisters of Charity Hospital, Buffalo, NY.
Published in the June issue of the Journal of Robotic Surgery, the paper provides peer-review confirmation that best practice, higher-volume robotic surgeons generate high profitability in benign robotic hysterectomy cases vs. identical laparoscopic cases.
“This publication is a testament to the work of Dr. Ghomi and the Catholic Health System surgical team of 47 Gyn surgeons who performed 985 cases (856 robotic, 129 laparoscopic) between January 2018 through December 2019,” said CAVA CEO Josh Feldstein.
CAVA Robotics International was engaged by Catholic Health to incorporate 21 dimensions of robotic program best practices into their robotic program. Driven by CAVA’s proprietary CAVAlytics® data analytics platform and learning management system, the collaboration between CAVA and Dr. Ghomi’s team achieved superior, cost-effective surgical performance, excellent clinical quality and higher profitability among their higher-volume robotic surgeons than comparative benign laparoscopic cases.
“Despite the rapid incorporation of robotic hysterectomy into clinical practice, prospective head-to-head evidence comparing robotic hysterectomy to traditional laparoscopy has been sparse,” said Dr. Herb Coussons, CAVA’s medical director. “This assessment establishes the important difference between a robotic program that achieves impressive economic and clinical results vs. one that is struggling fiscally and operationally,” Coussons said. “These results are reproducible with the application of CAVA best practices.”
“Our goal is to help surgeons and hospital administration realize the pathway to best practice robotic program performance,” said Feldstein. “It is indeed possible for robotic surgery to equal, and even exceed, laparoscopy in a good number of case types, such as benign hysterectomy.”
“With robotics procedures, we see significantly improved patient satisfaction,” said Dr. Coussons. “When robotic surgery programs are more cost-effective, we see the application of best practices leading to decreased surgical case times and costs as well as improved efficiency metrics that can exceed laparoscopy.”
However, despite nearly 20 years of clinical experience, the majority of hospitals still believe that robotic surgery takes too long and cost too much compared to laparoscopic procedures. “Based on a foundation of CAVA best practices, this study by Dr. Ghomi and his team provides important corroboration to hospitals around the world that robotic program optimization leads to improvement in both quality and profitability,” said Feldstein.
To the authors’ knowledge, the study, entitled “Robotic hysterectomy compared with laparoscopic hysterectomy: Is it still more costly to perform?” is the first economic analysis that focuses on the per-minute profitability of robotic hysterectomy within a healthcare system.
